HIV and AIDS Estimates

Similar documents
HIV and AIDS Estimates

HIV and AIDS Estimates

HIV and AIDS Estimates

HIV and AIDS Estimates

HIV and AIDS Estimates

GLOBAL AIDS MONITORING REPORT

Uganda. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015)

Cote D'Ivoire. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015)

Botswana. HIV Country Profile: Health expenditure, total (% of GDP) (2016) Total fertility rate (births per woman) ( )

UNGASS Indicators and possible adoption of NDPHS indicators. Tallinn /P.Leinikki

Eswatini. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015)

Country Assessments to Strengthen Adolescent Component of National HIV Programme

Program to control HIV/AIDS

In the Caribbean, the rate of new HIV infections, concentrated among key population, remained stable ART 8

WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections

Translating Science to end HIV in Latin America and the Caribbean

Sexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012

World Health Organization. A Sustainable Health Sector

FAST-TRACK COMMITMENTS TO END AIDS BY 2030

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030

Sierra Leone. HIV Epidemiology Report 2016

Prioritized research questions for adolescent HIV testing, treatment and service delivery

FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030

Linkages between Sexual and Reproductive Health and HIV

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016

STI and HIV Prevention and Care among Sex Workers

Sex Work in Sub-Saharan Africa : Opportunities and Challenges

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

Update on global guidelines. and emerging issues on perinatal HIV prevention. WHO 2013 Consolidated ARV Guidelines

The Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT

Overview of Paediatric HIV Treatment and Prevention: From Then to Now. Peter Mugyenyi, Joint Clinical Research Centre Kampala, Uganda

targets for HIV-positive children

HIV/AIDS MODULE. Rationale

Treat All : From Policy to Action - What will it take?

INTERNAL QUESTIONS AND ANSWERS DRAFT

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

Utilizing resources effectively for the first 90

IFMSA Policy Statement Ending AIDS by 2030

HIV in Zambia MINISTRY OF HEALTH. Dr Albert Mwango, BScHB, MBChB, MPH National Antiretroviral Program Coordinator,

Towards universal access

2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030

ADOLESCENTS AND HIV:

GLOBAL AIDS RESPONSE PROGRESS REPORT 2018

On the Fast-Track to end AIDS. HIV & AIDS in the Post 2015 Development Agenda

The elimination equation: understanding the path to an AIDS-free generation

HIV AND INFANT FEEDING

Annex 13. Indicators for HIV testing services reference sheet

HIV Treatment as Prevention (TasP)

WPR/RC68/7 page 7 ANNEX

Summary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017

Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84

Strategic use of antiretroviral drugs to prevent HIV transmission

Scaling up priority HIV/AIDS interventions in the health sector

The Global HIV/AIDS Program The World Bank. Building on Evidence: A Situational Analysis of the HIV Epidemic and Policy Response in Honduras

TOWARDS UNIVERSAL ACCESS

Global strategy on viral hepatitis and regional action plan: monitoring framework and 10 core indicators

The outlook for hundreds of thousands adolescents is bleak.

Diagnosing HIV/AIDS. Marissa Humphrey MSIV New York Medical College GE/NMF Scholar

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

Profilaxis Antiretroviral para la Prevención de la Infección VIH

Scaling Up Treatment in Zimbabwe: The path to high coverage

Partnerships between UNAIDS and the Faith-Based Community

SPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)

National HIV/STI Programme Overview

Assessment Schedule 2013 Health: Analyse an international health issue (91462)

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

CHAI Cambodia: HIV Program Update NCHADS Annual Operational Comprehensive Planning Workshop Dec 3, 2012

DEPARTMENT. Treatment Recommendations for. Pregnant and Breastfeeding Women: Critical Issues Consolidated ARV Guidelines. Dr.

Page 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions

ART for prevention the task ahead

The Global HIV Epidemic: Women in Africa and Haiti

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE

Progress against the HIV Epidemic: is the end in sight?

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

Anti Retroviral Traitment (ARVs)

Integrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China

Action plan for the health sector response to HIV in the WHO European Region DRAFT. istock//brauns

Monitoring of HIV positive mothers and HIV exposed infants in context of Option B+ implementation

Socio-demographic factors affecting HIV/AIDS in Kasungu District Malawi: A descriptive cross section study

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Module 1: HIV epidemiology, transmission and prevention

BUDGET AND RESOURCE ALLOCATION MATRIX

Country progress report - Bangladesh. Global AIDS Monitoring 2017

Review of the Democratic Republic of the Congo (DRC) by the Committee on the Elimination of Discrimination Against Women (CEDAW)

The President s Emergency Plan for AIDS Relief: Indicators, Reporting Requirements, and Guidelines for Focus Countries. Revised for FY2006 Reporting

WOMEN & HIV: A GLOBAL UPDATE. Deanna Kerrigan, PhD, MPH Associate Professor Health, Behavior & Society

Guidelines on safer conception in fertile HIV infected individuals

Hepatitis B stigma by association with HIV in Zambia

PROJECT BRIDGE: Differentiation of HIV Services for PWID in Harm Reduction Programs in Kazakhstan. Nabila El-Bassel, PhD Columbia University

Service coverage and mortality along the HIV care cascade in rural Uganda

Global Reporting System for Hepatitis (GRSH) An introduction. WHO Global Hepatitis Programme

Technical Guidance Note for Global Fund HIV Proposals

Aligning UNICEF s HIV Vision to the SDGs and UNAIDS Strategy. Dr. Chewe Luo Chief, HIV/AIDS Section UNICEF NYHQ 5 April 2016

HIV Situation in South-East Asia. HIV unit Department of Communicable Diseases

HUMAN SERVICES COMMISSION JANUARY 8, 2019 UNFINISHED BUSINESS HIV ZERO INITIATIVE END OF YEAR 2 EVALUATION REPORT

Pregnancies amongst adolescents and young women 16% of all births - 19% will have repeat pregnancies before age 20

Translating the Science to End New HIV Infections in Kenya

I S H I V S O R T E D? S U R V E Y H I G H L I G H T S

Transcription:

PARAGUAY HIV and AIDS Estimates Adults and children living with HIV Adults aged 15 and over living with HIV Women aged 15 and over living with HIV Men aged 15 and over living with HIV 20 000 [13 000-43 000] 19 000 [12 000-42 000] 5900 [3800-12 000] 14 000 [8500-30 000] Children aged 0 to 14 living with HIV <500 [<500 - <1000] Adult aged 15 to 49 HIV prevalence rate Women aged 15 to 49 HIV prevalence rate Men aged 15 to 49 HIV prevalence rate 0.5 [0.3-1.0] 0.3 [0.2-0.6] 0.6 [0.4-1.4] HIV prevalence among young women 0.2 [<0.1-0.4] HIV prevalence among young men 0.3 [0.1-0.7] Adults and children newly infected with HIV Adults aged 15 and over newly infected with HIV Women aged 15 and over newly infected with HIV Men aged 15 and over newly infected with HIV Children aged 0 to 14 newly infected with HIV HIV incidence per 1000 population (adults 15-49) HIV incidence per 1000 population (all ages) Adult and child deaths due to AIDS Deaths due to AIDS among adults aged 15 and over Deaths due to AIDS among women aged 15 and over 1400 [<1000-4900] 1300 [<1000-4700] <500 [<200-1300] <1000 [<500-3300] <100 [<100 - <200] 0.36 [0.16-1.24] 0.20 [0.09-0.72]... [... -...]... [... -...]... [... -...] Page 1

PARAGUAY Deaths due to AIDS among men aged 15 and over Deaths due to AIDS among children aged 0 to 14 Orphans due to AIDS aged 0 to 17... [... -...]... [... -...] 6500 [3300-11 000] Epidemic transition metrics Percent change in new HIV infections since 2010-1 Incidence-to-prevalence ratio 0.07 Incidence:mortality ratio... HIV testing and treatment cascade People living with HIV who know their status Percent of people living with HIV who know their status People living with HIV who have suppressed viral loads Percent of people living with HIV who have suppressed viral loads 14 000 68 [43 - >95] 4400 22 Antiretroviral therapy (ART) Coverage of adults and children receiving ART (%) Adults aged 15 and over receiving ART Women aged 15 and over receiving ART 39 [25-85] 39 [25-85] 44 [28-92] Men aged 15 and over receiving ART 37 [23-82] Children aged 0 to 14 receiving ART 49 [28-90] Number of adults and children receiving ART (#) Adults aged 15 and over receiving ART 7833 7647 Page 2

PARAGUAY Women aged 15 and over receiving ART 2582 Men aged 15 and over receiving ART 5065 Children aged 0 to 14 receiving ART 186 Adults and children newly-initiating ART (#) Adults aged 15 and over newly-initiating ART Children aged 0-14 newly-initiating ART 1605 1585 20 Women newly-initiating ART Men newly-initiating ART Adults and children known to be on ART 12 months after starting (%) Adults known to be on ART 12 months after starting Children known to be on ART 12 months after starting 79 79 81 Elimination of mother-to-child transmission Coverage of pregnant women who receive ARV for PMTCT (%) Pregnant women who received ARV for PMTCT (#) Pregnant women needing ARV for PMTCT (#) 61 [40 - >95] 214 <500 [<500 - <1000] Early infant diagnosis (%) 52 [26-80] New HIV infections averted due to PMTCT (%) <100 [<100 - <200] Sex workers Page 3

PARAGUAY Population size estimate (#) 5180 est. HIV prevalence (%) 1.34 Source: Prevalencia del V IH/Sífilis/Hepatiti s B Comportamie ntos, Prácticas y Actitudes de la Población MTS (Mujeres Trabajadoras Sexuales) en el Paraguay Condom use (%) 96 Source: "ESTUDIOS DE INVESTIGACIO MTS: Regiones de Estudio: Amambay, Asuncion, Central, Caaguazú, Alto Paraná, Pte. Hayes. " Active syphilis (%) 8.6 Source: ESTUDIOS DE I NVESTIGACIO Hepatitis B and coinfection with HIV (%) 0.2 Source: ESTUDIOS DE I NVESTIGACIO Hepatitis C and coinfection with HIV (%) Men who have sex with men Page 4

PARAGUAY Population size estimate (#) 15 868 est.; Coverage: Corresponden a 4 Regiones del pais HIV prevalence (%) 20.7 Source: Prevalencia de VIH Sífilis Hepatitis B, conocimientos, prácticas de riesgo y actitudes de hombres que tienen sexo con hombres (HSH) en Asunción, Central y Alto Paraná, Amambay y Caaguazú. Knowledge of HIV status (%) 80.3 Source: Estudio de Prevalencia del VIH/Sifilis, Hepatitis y comportamientos de riesgo en HSH Antiretroviral therapy coverage (%) 26.1 Source: Estudio de Prevalencia del VIH/Sifilis, Hepatitis y comportamientos de riesgo en HSH Condom use (%) 66.8 Source: Estudio de Prevalencia del VIH/Sifilis, Hepatitis y comportamientos de riesgo en HSH Page 5

PARAGUAY Active syphilis (%) 10.7 Source: Estudio de Prevalencia del VIH/Sifilis, Hepatitis y comportamientos de riesgo en HSH Hepatitis B and coinfection with HIV (%) 1.5 Source: ESTUDIOS DE I NVESTIGACIO Hepatitis C and coinfection with HIV (%) People who inject drugs Population size estimate (#) 5714 2013 est. Condom use (%) 44.7 Safe injecting practices (%) 92.1 Prisoners HIV prevention programmes in prisons: condoms distributed (#) 5659 Source: Routine programme data Transgender people Page 6

PARAGUAY Population size estimate (#) 719 est.; Coverage: Corresponde a datos sub-nacionales. HIV prevalence (%) 23.03 Source: PREVALENCIA DEL VIH/SIFILI S/HEPATITIS B Y COMPORTAM IENTOS, PRÁCTICAS Y ACTITUDES DE LA POBLACION TRANS EN EL PARAGUAY, Knowledge of HIV status (%) 86.9 Source: ESTUDIOS DE I NVESTIGACIO TRANS: Regiones de Estudio: Asunción, Central, Caaguazú, Alto Paraná. Antiretroviral therapy coverage (%) 60.7 Source: "ESTUDIOS DE INVESTIGACIO TRANS: Regiones de Estudio: Asunción, Central, Caaguazú, Alto Paraná." Page 7

PARAGUAY Condom use (%) 54.3 Source: ESTUDIOS DE I NVESTIGACIO Stigma and discrimination Sex workers: Avoidance of health care because of stigma and discrimination (%) 5.8 Refers to avoidance of HIV testing due to fear of stigma and discrimination; So urce: ESTUDIOS DE INVESTIGA CIO Men who have sex with men: Avoidance of health care because of stigma and discrimination (%) 23.6 Refers to avoidance of HIV testing due to fear of stigma and discrimination; Source: Estudio de Prevalencia del VIH/Sifilis, Hepatitis y comportamientos de riesgo en HSH Page 8

PARAGUAY Transgender people: Avoidance of health care because of stigma and discrimination (%) 6.3 Refers to avoidance of HIV medical care due to fear of stigma and discrimination; Source: PREVALENCIA DEL VIH/SIFILI S/HEPATITIS B Y COMPORTAM IENTOS, PRÁCTICAS Y ACTITUDES DE LA POBLACION TRANS EN EL PARAGUAY, Young people Knowledge about HIV prevention among young people aged 15-24 Knowledge about HIV prevention among young women aged 15-24 undefined 27.5 Source: MICS 2016 Knowledge about HIV prevention among young men aged 15-24 Hepatitis and HIV Page 9

PARAGUAY Hepatitis B testing 48.7 Source: Base Electronica de Diagnosticos de Hepatitis del Laboratorio del PRONASIDA, Planilla electrónica de Registro de inicio de TARV de los SAI, Registro de retiros de ARV de la Farmacia del PRONASIDA. Proportion of people coinfected with HIV and HBV receiving combined treatment 96.5 Source: Base Electronica de Diagnosticos de Hepatitis del Laboratorio del PRONASIDA Hepatitis C testing 43.7 Source: Base Electronica de Diagnosticos de Hepatitis del Laboratorio del PRONASIDA, Planilla electrónica de Registro de inicio de TARV de los SAI, Registro de retiros de ARV de la Farmacia del PRONASIDA. Page 10